Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma?

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 17110124)

Published in Eur J Cardiothorac Surg on November 15, 2006

Authors

Ottavio Rena1, Esther Papalia, Alberto Oliaro, Enrico Ruffini, Pierluigi Filosso, Domenico Novero, Giuliano Maggi, Caterina Casadio

Author Affiliations

1: Thoracic Surgery Department, University of Eastern Piedmont 'A. Avogadro', Novara, Italy. ottaviorena@libero.it

Articles citing this

A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management. Br J Cancer (2007) 0.85

Thymic neoplasm: a rare disease with a complex clinical presentation. J Thorac Dis (2013) 0.83

Postoperative radiation therapy for non-small cell lung cancer and thymic malignancies. Cancers (Basel) (2012) 0.81

Treatment results and prognostic indicators in thymic epithelial tumors: a clinicopathological analysis of 45 patients. Iran J Med Sci (2014) 0.78

Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy. Oncol Lett (2016) 0.78

Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor? Cancer Res Treat (2012) 0.77

Modified maximal thymectomy for thymic epithelial tumors: predictors of survival and neurological outcome in patients with thymomatous myasthenia gravis. World J Surg (2009) 0.76

Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma-An Analysis of the International Thymic Malignancies Interest Group Retrospective Database. J Thorac Oncol (2016) 0.75

The clinical features, diagnosis and management of recurrent thymoma. J Cardiothorac Surg (2016) 0.75

Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies. Onco Targets Ther (2016) 0.75

Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen. Onco Targets Ther (2015) 0.75

The role of adjuvant chemotherapy following resection of early stage thymoma. Ann Cardiothorac Surg (2016) 0.75

Articles by these authors

Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients. J Thorac Oncol (2014) 2.81

Posttraumatic and iatrogenic foreign bodies in the heart: report of fourteen cases and review of the literature. J Thorac Cardiovasc Surg (2003) 2.61

Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol (2012) 2.57

First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial. J Clin Oncol (2011) 1.84

Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience. Eur J Cardiothorac Surg (2002) 1.79

Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature. J Thorac Cardiovasc Surg (2004) 1.65

Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study. PLoS One (2013) 1.55

Stereotactic body radiation therapy for lung metastases. Lung Cancer (2011) 1.52

Long-term results after treatment for recurrent thymoma: a multicenter analysis. J Thorac Oncol (2014) 1.47

Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study. J Thorac Cardiovasc Surg (2005) 1.47

Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas. Am J Clin Pathol (2005) 1.43

Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms. Ann Thorac Surg (2009) 1.40

Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience. Eur J Cardiothorac Surg (2010) 1.40

Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood (2006) 1.38

ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol (2014) 1.37

European guidelines on structure and qualification of general thoracic surgery. Eur J Cardiothorac Surg (2014) 1.35

World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer (2005) 1.31

Bronchial carcinoid tumors: surgical management and long-term outcome. J Thorac Cardiovasc Surg (2002) 1.29

Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol (2003) 1.27

Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion. Cancer Res (2002) 1.26

A review of prognostic factors in thymic malignancies. J Thorac Oncol (2011) 1.24

Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy. J Clin Oncol (2010) 1.21

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 1.21

Ten years of descending necrotizing mediastinitis: management of 23 cases. J Oral Maxillofac Surg (2007) 1.19

S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. Am J Pathol (2002) 1.17

Successful surgical management of a delayed pharyngo-esophageal perforation after anterior cervical spine plating. Eur Spine J (2008) 1.17

Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study. Haematologica (2009) 1.15

Efficacy and safety of human fibrinogen-thrombin patch (TachoSil®) in the treatment of postoperative air leakage in patients submitted to redo surgery for lung malignancies: a randomized trial. Interact Cardiovasc Thorac Surg (2013) 1.13

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 1.12

Development of the international thymic malignancy interest group international database: an unprecedented resource for the study of a rare group of tumors. J Thorac Oncol (2014) 1.10

Neuroendocrine tumors of the thymus. Thorac Surg Clin (2011) 1.09

Radical resection of a giant, invasive and symptomatic malignant Solitary Fibrous Tumour (SFT) of the pleura. Lung Cancer (2008) 1.09

Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood (2002) 1.08

Adenosquamous lung carcinomas: a histologic subtype with poor prognosis. Lung Cancer (2011) 1.08

Malignant solitary fibrous tumors of the pleura: retrospective review of a multicenter series. J Thorac Oncol (2012) 1.07

Tapias score for predicting recurrences in resected solitary fibrous tumor of the pleura: controversial points and future perspectives emerging from an external validation. Chest (2015) 1.06

Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure. Lung Cancer (2012) 1.04

Air-leak management after upper lobectomy in patients with fused fissure and chronic obstructive pulmonary disease: a pilot trial comparing sealant and standard treatment. Interact Cardiovasc Thorac Surg (2009) 1.04

Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something? J Thorac Oncol (2011) 1.04

The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies. J Thorac Oncol (2013) 1.00

Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta. Lung Cancer (2008) 1.00

Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significance. Eur J Cardiothorac Surg (2002) 1.00

Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? Hematol Oncol (2009) 0.98

Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations. J Surg Oncol (2011) 0.98

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 0.98

Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance. Eur J Cardiothorac Surg (2007) 0.96

Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Lung Cancer (2006) 0.96

Utility of flow cytometry immunophenotyping in fine-needle aspirate cytologic diagnosis of non-Hodgkin lymphoma: A series of 252 cases and review of the literature. Appl Immunohistochem Mol Morphol (2010) 0.95

IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor. PLoS One (2006) 0.95

CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? Blood (2008) 0.94

Completion pneumonectomy: a multicentre international study on 165 patients. Eur J Cardiothorac Surg (2012) 0.92

Human pulmonary dirofilariasis: uncommon cause of pulmonary coin-lesion. Eur J Cardiothorac Surg (2002) 0.91

The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system. Eur J Cardiothorac Surg (2008) 0.91

Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee. J Thorac Oncol (2014) 0.90

Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung. Eur J Cardiothorac Surg (2003) 0.90

Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study. Eur J Cardiothorac Surg (2013) 0.89

Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer (2007) 0.88

Primary malignant melanoma of the bronchus intermedius. J Thorac Cardiovasc Surg (2003) 0.88

Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients. Cancer J (2010) 0.88

Stage I non-small cell lung carcinoma: really an early stage? Eur J Cardiothorac Surg (2002) 0.88

World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group. Hum Pathol (2010) 0.88

Synchronous bilateral typical carcinoid of the lung. Eur J Cardiothorac Surg (2003) 0.87

Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa. Int J Oncol (2010) 0.87

The use of video-assisted thoracic surgery in the management of Pancoast tumors. Interact Cardiovasc Thorac Surg (2010) 0.87

Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area. Genes Chromosomes Cancer (2014) 0.87